Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Feasibility Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease

NCT02359864 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT02359864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02359864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Feasibility Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease
Lead sponsor
Corewell Health East
Phase
Not applicable
Overall status
Terminated
Start date
October 1, 2019
Completion date
February 3, 2021
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease